Colleen Flesher appointed new Co-CEO of Vimian’s MedTech segment and member of the Vimian group management team

Colleen Flesher has more than twenty years of experience from leadership positions in the global MedTech sector. Colleen Flesher joined Movora as COO in October after three years as President & General Manager for Lima Corporate in the US, a leading provider of orthopedic implants to human healthcare. Prior to that she spent almost ten years at Johnson & Johnson’s MedTech divisions in various managerial positions within sales, marketing, product development and innovation.

Colleen assumes her position as Co-CEO of Movora and member of Vimian’s management team, alongside Co-CEO Guy Spörri, on 1 December. She succeeds Patrick Gendreau and Christopher Sidebotham who have decided to step down after more than thirty years as founders and leaders of Veterinary Orthopedic Implants (VOI) and Biomedtrix.

“I would like to sincerely thank Patrick and Chris who over the past thirty years have founded and grown two successful, leading orthopedics businesses in the US with remarkable commercial and innovation capabilities. I am thankful for their exceptional leadership throughout the integration into Vimian and the formation of Movora, today a global leader in veterinary orthopedics, says Dr. Fredrik Ullman, CEO of Vimian Group and continues:

“Colleen Flesher is a highly appreciated leader with significant experience from the MedTech sector. With Colleen onboard, we are now ready to take the next step in our succession plans for Movora. Together with Co-CEO Guy Spörri and the rest of the leadership team in Movora, we will continue to deliver on our strategic agenda strengthening and broadening our global position in veterinary MedTech”.

Colleen Flesher assumes her position as Co-CEO of Movora on 1 December. Christopher Sidebotham will remain in the company as senior advisor with focus on R&D and innovation.